⚖ Oral Arguments, with Context

Real court arguments, crisp audio, with context.

Court recordings can be difficult to follow, and many suffer from poor audio quality. This podcast enhances the audio, provides a brief introduction to each case, and explains legal concepts that may be unfamiliar to some listeners.

We hope these enhancements make oral argument recordings easier to understand, more accessible, and more enjoyable to listen to.

Apple Podcasts Spotify YouTube /feed.xml Open RSS

Novartis Pharmaceuticals v. Drummond — 10th Cir. (Sep 17, 2026)

No. 25-6182 Argued September 17, 2026 Published September 20, 2026

The Tenth Circuit reviews an order blocking part of Oklahoma's 2025 340B Nondiscrimination Act. The federal 340B program requires participating drugmakers to discount outpatient drugs for qualifying hospitals and clinics, known as covered entities. Those providers may use outside contract pharmacies to dispense the drugs. Oklahoma's law barred manufacturers from restricting delivery to those pharmacies or requiring claims data as a delivery condition. Novartis, AbbVie, and AstraZeneca sued before the law took effect. The district court preliminarily blocked the delivery rule and its penalty provision. This recording covers the Novartis and related AbbVie appeals. Garry Gaskins for Oklahoma will say federal law leaves drug delivery to the states. Jessica Ellsworth for Novartis and Matthew Owen for AbbVie will say the law changes the federal program and compels additional discounted sales. Maxwell Baldi will appear for the United States; his shared argument continues in the companion AstraZeneca recording.

Novartis Pharmaceuticals v. Drummond (No. 25-6182) — U.S. Court of Appeals for the Tenth Circuit, argued September 17, 2026.

Sources
Argument audio — U.S. Court of Appeals for the Tenth Circuit (public domain, 17 U.S.C. § 105):https://www.ca10.uscourts.gov/sites/ca10/files/oralarguments/25-6182.mp3
Argument listing — U.S. Court of Appeals for the Tenth Circuit:https://www.ca10.uscourts.gov/oralargument/search-results?field_oa_hearing_date_value%5Bmin%5D%5Bdate%5D=09%2F17%2F2026&field_oa_hearing_date_value%5Bmax%5D%5Bdate%5D=09%2F20%2F2026
Preliminary-injunction order — U.S. District Court for the Western District of Oklahoma:https://oklahoma.gov/content/dam/ok/en/oag/news-documents/2025/november/340B%20PI%20Order.pdf
Oklahoma House Bill 2048 — Oklahoma Legislature:https://www.oklegislature.gov/cf_pdf/2025-26%20ENR/hB/HB2048%20ENR.PDF
340B program requirements — Health Resources and Services Administration:https://www.hrsa.gov/opa/program-requirements
340B contract-pharmacy services — Health Resources and Services Administration:https://www.hrsa.gov/opa/implementation-contract
Novartis district-court docket — Justia:https://dockets.justia.com/docket/oklahoma/okwdce/5:2025cv00727/131727
Novartis appeal docket — Justia:https://dockets.justia.com/docket/circuit-courts/ca10/25-6182
Related AbbVie district-court docket — Justia:https://dockets.justia.com/docket/oklahoma/okwdce/5:2025cv00726/131726
Related AbbVie appeal docket — Justia:https://dockets.justia.com/docket/circuit-courts/ca10/25-6184
Companion argument audio — U.S. Court of Appeals for the Tenth Circuit:https://www.ca10.uscourts.gov/sites/ca10/files/oralarguments/25-6183.mp3

0:00
0:00